News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 747 results

Bio-Techne takes patent dispute to UK

UK27-09-2022Staff Writer

The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech.

EMA backs switch to biosimilars

EU22-09-2022Muireann Bolger

Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.

Swiss watchdog investigates Novartis over patent use

Switzerland20-09-2022Staff Writer

Authority carries out dawn raid at Novartis’ premises | Probe focuses on the alleged unlawful use of a skincare patent to bar competition

Microsoft partners with Nordic data science firm on AI project

Denmark, US13-09-2022Staff Writer

Deal set to enable faster use of artificial intelligence in drug discovery | Planned AI models to identify novel targets and establish biomarkers of disease.

Big pharma firm hits back in COVID-19 tech dispute

Germany, UK06-09-2022Staff Writer

CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid

Novo Nordisk makes $1.1bn bid for biopharma company

Denmark, US02-09-2022Staff Writer

Massachusetts-based target company specialises in rare blood disorders | Deal gives Novo Nordisk access to lead development candidate, etavopivat.

Carpmaels & Ransford adds partner with UPC focus

EU01-09-2022Sarah Speight

New partner brings pharma and chemistry focus, and boosts the European firm’s Unified Patent Court team.

UK pharma firm ‘stole’ psilocybin secrets from professor

UK, US09-08-2022Staff Writer

Mental health specialists in dispute over psilocybin | Terran Biosciences accuses Compass Pathways of ‘milking’ professor before ‘secretly’ filing a patent for the medicine.

Competition watchdog fines big pharma duo £70m

UK22-07-2022Staff writer

The pair are rapped for overcharging the NHS | Unfair prices for an epilepsy drug lasted four years | Costs leapt from £2m to £50m in one year after the companies' “illegal exploitation” of market position.

Bad news for Italy’s EMA relocation challenge

EU, Italy15-07-2022

EU’s top court denies bid that Amsterdam decision was a “misuse of powers” | Complaint said The Netherlands facility wasn’t ready | Milan lost out after random pick from a fish bowl.

Showing 1 to 10 of 747 results

LSIPR